Equities evaluation analysts predict that Natera, Inc. (NASDAQ:NTRA) will submit $168.10 million in gross sales for The current quarter, Based mostly on Zacks. 5 analysts have currentd estimates for Natera’s earnings, with The backside gross sales estimate coming in at $166.63 million and The very biggest estimate coming in at $169.37 million. Natera reported gross sales of $112.40 million Inside the identical quarter final yr, which signifies a constructive yr over yr progress price of 49.6%. The agency is scheduled to problem its subsequent quarterly earnings outcomes on Thursday, February Twenty fourth.

On common, analysts anticipate that Natera will report full-yr gross sales of $621.32 million for The current yr, with estimates Starting from $619.09 million to $625.15 million. For The subsequent monetary yr, analysts forecast that the enterprise will report gross sales of $766.31 million, with estimates Starting from $752.37 million to $786.29 million. Zacks’ gross sales commons are A imply based on a survey of evaluation analysts that that current safety for Natera.

Natera (NASDAQ:NTRA) final problemd its earnings outcomes on Thursday, November 4th. The medical evaluation agency reported ($1.63) earnings per share (EPS) for the quarter, lacking the consensus estimate of ($1.27) by ($0.36). Natera had a adverse internet margin of 72.15% and a adverse return on equity of 85.05%. The agency had income of $158.10 million By way of the quarter, As in contrast with analyst estimates of $151.92 million. All through The identical quarter in the earlier yr, the agency submited ($0.72) EPS. The agency’s quarterly income was up 61.2% on a yr-over-yr basis.

A quantity of evaluation corporations recently commented on NTRA. Piper Sandler started safety on shares of Natera in a evaluation report on Thursday, January Sixth. They problemd an “obese” rating and a $110.00 worth goal for the agency. Robert W. Baird upped their worth goal on shares of Natera from $145.00 to $152.00 and gave the …….

Source: https://www.marketbeat.com/instant-alerts/nasdaq-ntra-consensus-analyst-rating-2022-01-2-3/